Of particular interest is that both Meeter and colleagues [11] and van der Ende and colleagues [37] showed that in genetic FTD cases, the serum concentration of NfL is clearly higher in symptomatic versus asymptomatic mutation carriers. The gene discussed is NEFL; the disease is frontotemporal dementia.